Temporary ventricular assist devices in the intensive care unit as a bridge to decision

AACN Advanced Critical Care

Volumn 23, Issue 1, 2012, Pages 55-68

  Myers, Timothy J ^a  

^a Medical and Scientific Consulting Services LLC   (United States)

Author keywords

bridge to decision; cardiogenic shock; ventricular assist device

Indexed keywords

CARDIOGENIC SHOCK; COOPERATION; CRITICAL ILLNESS; DECISION MAKING; HEART ASSIST DEVICE; HEART FAILURE; HEART OUTPUT; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INSTRUMENTATION; INTENSIVE CARE UNIT; METHODOLOGY; REVIEW; TIME;

CARDIAC OUTPUT; COOPERATIVE BEHAVIOR; CRITICAL ILLNESS; DECISION MAKING; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 84856855291     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e318240e369     Document Type: Article

References (75)

1. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective. Circulation. 2009; 119: 1211-1219.
2. Barron HV, Every NR, Parsons LS, et al. The use of intraaortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933-939.
3. Jeger RV, Lowe AM, Buller CE, et al. Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: A report from the shock trial. Chest. 2007;132:1794-1803.
4. Menon V, Fincke R. Cardiogenic shock: A summary of the randomized shock trial. Congest Heart Fail. 2003;9:35-39.
5. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: A report from the Shock Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000;36:1063-1070.
6. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216. (Pubitemid 40348525)
7. Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302-311, 311.e1.
8. Paul S, Leacche M, Unic D, et al. Determinants of outcomes for postcardiotomy VAD placement: An 11-year, two-institution study. J Card Surg. 2006;21:234-237.
9. Sylvin EA, Stern DR, Goldstein DJ. Mechanical support for postcardiotomy cardiogenic shock: Has progress been made? J Card Surg. 2010;25:442-454.
10. Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist devices: Clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010;24:478-486.
11. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007;134:351-358. (Pubitemid 47088583)
12. Webb JG, Sleeper LA, Buller CE, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: A report from the Shock Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000;36:1084-1090.
13. Moriguchi J, Davis S, Jocson R, et al. Successful use of a pneumatic biventricular assist device as a bridge to transplantation in cardiogenic shock. J Heart Lung Transplant. 2011;30:1143-1147.
14. Jeger RV, Harkness SM, Ramanathan K, et al. Emergency revascularization in patients with cardiogenic shock on admission: A report from the Shock Trial and Registry. Eur Heart J. 2006;27:664-670.
15. Unosawa S, Hata M, Sezai A, et al. Successful management of fulminant myocarditis with left ventricular assist device: Report of a severe case. Ann Thorac Cardiovasc Surg. 2010;16:48-51.
16. Fayssoil A, Nardi O, Orlikowski D, Combes A, Chastre J, Annane D. Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis. Ann Thorac Surg. 2010;89:614-616.
17. Khalife WI, Kar B. The TandemHeart PVA in the treatment of acute fulminant myocarditis. Tex Heart Inst J. 2007; 34:209-213. (Pubitemid 47066600)
18. Oosterom L, de Jonge N, Kirkels J, Klopping C, Lahpor J. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J. 2008;16:426-428.
19. Goldstein D, Neragi-Miandoab S. Mechanical bridge to decision: What are the options for the management of acute refractory cardiogenic shock? Curr Heart Fail Rep. 2011;8:51-58.
20. El-Banayosy A, Arusoglu L, Kizner L, Fey O, Minami K, Korfer R. Complications of circulatory assist. Perfusion. 2000;15:327-331. (Pubitemid 30438710)
21. Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock. Crit Care Med. 2008;36:S66-S74.
22. Samuels LE, Darze ES. Management of acute cardiogenic shock. Cardiol Clin. 2003;21:43-49. (Pubitemid 36612702)
23. Park SJ, Nguyen DQ, Bank AJ, Ormaza S, Bolman RM III. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg. 2000;69:1146-1151. (Pubitemid 30259376)
24. Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: Comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006;25:504-509. (Pubitemid 44308155)
25. Myers TJ, Khan T, Frazier OH. Infectious complications associated with ventricular assist systems. ASAIO J. 2000;46:S28-S36.
26. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: Etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90:1270-1277.
27. Goldstein DJ, Beauford RB. Left ventricular assist devices and bleeding: Adding insult to injury. Ann Thorac Surg. 2003;75:S42-S47. (Pubitemid 36677189)
28. Slaughter MS, Sobieski MA, Gallagher C, Graham J, Brandise J, Stein R. Fibrinolytic activation during longterm support with the HeartMate II left ventricular assist device. ASAIO J. 2008;54:115-119.
29. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 1996;112:1090-1097. (Pubitemid 26339283)
30. Walker PC, Depestel DD, Miles NA, Malani PN. Surgical infection prophylaxis for left ventricular assist device implantation. J Card Surg. 2011;26(4):440-443.
31. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: Prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461-470. (Pubitemid 41076784)
32. Holman WL, Pamboukian SV, Blood M, Tallaj JA, McGiffin DC, Kirklin JK. Managing device infections: Are we progressing or is infection an insurmountable obstacle? ASAIO J. 2005;51:452-455. (Pubitemid 41076782)
33. Patel ND, Weiss ES, Schaffer J, et al. Right heart dysfunction after left ventricular assist device implantation: A comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg. 2008;86:832-840; discussion 832-840.
34. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1-6. (Pubitemid 43049657)
35. Cleveland JC Jr, Naftel DC, Reece TB, et al. Survival after biventricular assist device implantation: An analysis of the interagency registry for mechanically assisted circulatory support database. J Heart Lung Transplant. 2011; 30:862-869.
36. Barnes K. Complications in patients with ventricular assist devices. Dimens Crit Care Nurs. 2008;27:233-241; quiz 242-243.
37. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-S39.
38. Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423-427.
39. Christensen DM. Physiology of continuous-flow pumps. AACN Adv Crit Care. 2012;23:46-54.
40. Arlt M, Philipp A, Voelkel S, et al. Hand-held minimised extracorporeal membrane oxygenation: A new bridge to recovery in patients with out-of-centre cardiogenic shock. Eur J Cardiothorac Surg. 2011;40:689-694.
41. Arlt M, Philipp A, Voelkel S, et al. Extracorporeal membrane oxygenation in severe trauma patients with bleeding shock. Resuscitation. 2010;81:804-809.
42. Kouretas PC, Kaza AK, Burch PT, et al. Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs. 2009;33: 1002-1004.
43. Hirata Y, Charette K, Mosca RS, Quaegebeur JM, Chen JM. Pediatric application of the Thoratec CentriMag BIVAD as a bridge to heart transplantation. J Thorac Cardiovasc Surg. 2008;136:1386-1387.
44. Saeed D, Kizner L, Arusoglu L, et al. Prolonged transcutaneous cardiopulmonary support for postcardiotomy cardiogenic shock. ASAIO J. 2007;53:e1-e3. (Pubitemid 46791553)
45. Aziz TA, Singh G, Popjes E, et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant. 2010;29:66-71.
46. Fitzgerald D, Ging A, Burton N, Desai S, Elliott T, Edwards L. The use of percutaneous EMO support as a "bridge to bridge" in heart failure patients: A case report. Perfusion. 2010;25:321-325, 327.
47. Loforte A, Montalto A, Lilla Della Monica P, Musumeci F. Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact Cardiovasc Thorac Surg. 2010;10:847-850.
48. Jaroszewski DE, Marranca MC, Pierce CN, et al. Successive circulatory support stages: A triple bridge to recovery from fulminant myocarditis. J Heart Lung Transplant. 2009;28:984-986.
49. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971-976.
50. Shuhaiber JH, Jenkins D, Berman M, et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 2008;27:158-164. (Pubitemid 351222639)
51. Khan NU, Al-Aloul M, Shah R, Yonan N. Early experience with the Levitronix CentriMag device for extra-corporeal membrane oxygenation following lung transplantation. Eur J Cardiothorac Surg. 2008;34:1262-1264.
52. John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-939.
53. Haj-Yahia S, Birks EJ, Amrani M, et al. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg. 2009;138:227-230.
54. De Robertis F, Rogers P, Amrani M, et al. Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant. 2008;27: 474-478. (Pubitemid 351602178)
55. Gregoric ID, Cohn WE, Akay MH, La Francesca S, Myers T, Frazier OH. CentriMag left ventricular assist system: Cannulation through a right minithoracotomy. Tex Heart Inst J. 2008;35:184-185. (Pubitemid 351988649)
56. Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110-111.
57. Kiernan MS, Krishnamurthy B, Kapur NK. Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction. J Invasive Cardiol. 2010;22: E23-E26.
58. Kar B, Forrester M, Gemmato C, et al. Use of the Tandem- Heart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006;18:93-96.
59. Gregoric ID, Bruckner BA, Jacob L, et al. Techniques and complications of TandemHeart ventricular assist device insertion during cardiac procedures. ASAIO J. 2009;55: 251-254.
60. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469.e1-e8.
61. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688-696.
62. Kar B, Adkins LE, Civitello AB, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006;33:111-115. (Pubitemid 44299837)
63. Dhar G, Jolly N. Mechanical versus pharmacologic support for cardiogenic shock. Catheter Cardiovasc Interv. 2010;75:626-629.
64. Ferreiro JL, Gomez-Hospital JA, Cequier AR, et al. Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention. Int J Cardiol. 2010;1145:235-237.
65. Garatti A, Colombo T, Russo C, et al. Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant. 2005;24:481-485. (Pubitemid 40403807)
66. Granfeldt H, Hellgren L, Dellgren G, et al. Experience with the Impella recovery axial-flow system for acute heart failure at three cardiothoracic centers in Sweden. Scand Cardiovasc J. 2009;43:233-239.
67. Iliodromitis KE, Kahlert P, Plicht B, et al. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support. Int J Cardiol. 2011;153(1):59-63.
68. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials. Eur Heart J. 2009;30:2102-2108.
69. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial U.S. Experience. JACC Cardiovasc Interv. 2009;2:91-96.
70. Siegenthaler MP, Brehm K, Strecker T, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: A three-center experience. J Thorac Cardiovasc Surg. 2004;127:812-822. (Pubitemid 38316188)
71. Lamarche Y, Cheung A, Ignaszewski A, et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg. 2011;142:60-65.
72. Joyce DL, Conte JV, Russell SD, Joyce LD, Chang DC. Disparities in access to left ventricular assist device therapy. J Surg Res. 2009;152:111-117.
73. Jaroszewski DE, Kleisli T, Staley L, et al. A traveling team concept to expedite the transfer and management of unstable patients in cardiopulmonary shock. J Heart Lung Transplant. 2011;30:618-623.
74. Gonzalez-Stawinski GV, Chang AS, Navia JL, et al. Regional referral system for patients with acute mechanical support: Experience at the Cleveland Clinic Foundation. ASAIO J. 2006;52:445-449. (Pubitemid 44174633)
75. Helman DN, Oz MC. Developing a comprehensive mechanical support program. J Card Surg. 2001;16:203-208. (Pubitemid 34074976)